Dr. Nitin Jain, MD
Claim this profileM D Anderson Cancer Center
Area of expertise
Acute Lymphocytic Leukemia
Nitin Jain, MD has run 8 trials for Acute Lymphocytic Leukemia. Some of their research focus areas include:
Chronic Lymphocytic Leukemia
Nitin Jain, MD has run 8 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
University Of Texas MD Anderson Cancer Center
Clinical Trials Nitin Jain, MD is currently running
Triple Therapy
for Chronic Lymphocytic Leukemia
To learn if the combination of pirtobrutinib (also called LOXO-305), venetoclax, and obinutuzumab is safe and effective when given to patients with chronic lymphocytic leukemia (CLL) or Richter transformation (RT) who have not previously received treatment.
Recruiting
1 award
Phase 2
UCART22
for Acute Lymphoblastic Leukemia
This is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The purpose of this study is to evaluate the safety and clinical activity of UCART22 and determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Recruiting
1 award
Phase 1 & 2
More about Nitin Jain, MD
Clinical Trial Related
9 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Nitin Jain, MD has experience with
- Venetoclax
- Ibrutinib
- Obinutuzumab
- Cyclophosphamide
- ADCT-602
- Atezolizumab
Breakdown of trials Nitin Jain, MD has run
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nitin Jain, MD specialize in?
Nitin Jain, MD focuses on Acute Lymphocytic Leukemia and Chronic Lymphocytic Leukemia. In particular, much of their work with Acute Lymphocytic Leukemia has involved CD19 positive patients, or patients who are IGHV positive.
Is Nitin Jain, MD currently recruiting for clinical trials?
Yes, Nitin Jain, MD is currently recruiting for 5 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Nitin Jain, MD has studied deeply?
Yes, Nitin Jain, MD has studied treatments such as Venetoclax, Ibrutinib, Obinutuzumab.
What is the best way to schedule an appointment with Nitin Jain, MD?
Apply for one of the trials that Nitin Jain, MD is conducting.
What is the office address of Nitin Jain, MD?
The office of Nitin Jain, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.